Viome Life Sciences

United States - Bellevue, Washington

• 10/11/2021
• Pre-Series C
• $54,000,000

Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting and preventing chronic diseases, cancers, and aging through a deeper understanding of an individual's biology at a molecular level.

Viome's Consumer Services (VIOME) provides the industry's only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need.

Our Health Sciences division focuses on key initiatives including prediction, early diagnostics, prognostics, and precision therapeutics to help people live a disease free life. With our state of the art artificial intelligence platform, we are able to analyze data from the world's largest and richest gene expression database in order to identify the root causes of chronic diseases, cancers, and aging and the mechanisms of action to be able to prevent and reverse them.

Prediction: Using advanced AI methods to discover host/microbial biomarkers that predict the risk of developing severe chronic conditions, including cancers.

Early Diagnostics: Using host/microbial biomarkers to diagnose severe chronic conditions including cancers at the earliest possible stage. Early diagnosis will enable earlier treatment which often is associated with higher efficacy.

Prognostics: Leveraging host/microbial biomarkers to develop companion diagnostics to predict drug effectiveness and further improve responsiveness of patients by proposing AI-guided modulation of the microbiome.

Therapeutics: By targeting the root cause of specific chronic diseases with prophylactics or therapeutics such as drugs, monoclonal antibodies, vaccines, phages, or other appropriate modalities.

Related People

Naveen JainFounder

United States - Bellevue, Washington,

Naveen is an intensely curious entrepreneur who is focused on ideas that will push humanity forward. He is the author of the award-winning book Moonshots: Creating a World of Abundance. His current moonshot adventures are Viome and Moon Express. As a serial entrepreneur, he previously founded InfoSpace, Intelius, and TalentWise.

Viome’s singular mission is to “make illness optional.” Viome has built an AI-driven platform that analyzes the interaction between food, our microbiome, and our human cells in order to develop precision nutrition to prevent and reverse chronic diseases.

Moon Express is the only company globally with permission to harvest resources from the moon—developing the infrastructure needed to push humanity forward towards a true multi-planetary society.

In addition to his current moonshots, he is the Vice-Chairman of the Board at Singularity University, where he focuses on educating and inspiring leaders to utilize innovative technologies to address humanity’s greatest challenges. He is also on the Board of the XPRIZE Foundation, an organization that uses incentivized prize competition to push the limits of what’s possible — to change the world for the better.

Naveen has been the recipient of many honors for his entrepreneurial successes. These include:
“Entrepreneur of the Year” by Ernst & Young, “Most Creative Person” by Fast Company, “Top 20 Entrepreneurs” & “Lifetime Achievement Award” for the leadership by Red Herring. “Medal of Honor” by Ellis Island, and “Top 50 Philanthropists” by Town & Country Magazine.

LinkedIn https://www.linkedin.com/in/naveenjainintelius/